>
Switch to:

Corcept Therapeutics Days Sales Outstanding

: 27.88 (As of Dec. 2020)
View and export this data going back to 2004. Start your Free Trial

Corcept Therapeutics's Accounts Receivable for the three months ended in Dec. 2020 was $26.2 Mil. Corcept Therapeutics's Revenue for the three months ended in Dec. 2020 was $85.7 Mil. Hence, Corcept Therapeutics's days sales outstanding for the three months ended in Dec. 2020 was 27.88.

NAS:CORT' s Days Sales Outstanding Range Over the Past 10 Years
Min: 23.73   Med: 44.26   Max: 61.48
Current: 27.02
23.73
61.48

During the past 13 years, Corcept Therapeutics's highest Days Sales Outstanding was 61.48. The lowest was 23.73. And the median was 44.26.

NAS:CORT's Days Sales Outstanding is ranked higher than
83% of the 744 Companies
in the Biotechnology industry.

( Industry Median: 66.80 vs. NAS:CORT: 27.02 )

Corcept Therapeutics's days sales outstanding increased from Dec. 2019 (20.69) to Dec. 2020 (27.88).

Corcept Therapeutics Days Sales Outstanding Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Corcept Therapeutics Annual Data
Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Days Sales Outstanding Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 44.26 35.08 25.55 23.73 27.02

Corcept Therapeutics Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
Days Sales Outstanding Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.69 26.11 23.41 23.21 27.88
Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.

Corcept Therapeutics Days Sales Outstanding Distribution

* The bar in red indicates where Corcept Therapeutics's Days Sales Outstanding falls into.


Corcept Therapeutics Days Sales Outstanding Calculation

Days sales outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Corcept Therapeutics's Days Sales Outstanding for the fiscal year that ended in Dec. 2020 is calculated as

Days Sales Outstanding=Accounts Receivable/Revenue*Days in Period
=26.198/353.874*365
=27.02

Corcept Therapeutics's Days Sales Outstanding for the quarter that ended in Dec. 2020 is calculated as:

Days Sales Outstanding=Accounts Receivable/Revenue*Days in Period
=26.198/85.735*365 / 4
=27.88

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Corcept Therapeutics  (NAS:CORT) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Corcept Therapeutics Days Sales Outstanding Related Terms

Corcept Therapeutics Days Sales Outstanding Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)